Novartis to Shire Said to Weigh Bids for ThromboGenics

... Representatives for ThromboGenics, Dublin-based Shire, Novartis, Valeant, Allergan and Roche declined to comment. Tarrytown, New York-based Regeneron couldn't be immediately reached for comment. ThromboGenics' main product is Jetrea, an injection to ...

http://ift.tt/1gwU76I